Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (49) 49
index medicus (42) 42
oncology (42) 42
melanoma (38) 38
article (26) 26
chemistry (26) 26
metallurgy (26) 26
biochemistry (25) 25
female (25) 25
beer (23) 23
enzymology (23) 23
microbiology (23) 23
mutation or genetic engineering (23) 23
spirits (23) 23
vinegar (23) 23
wine (23) 23
human necessities (22) 22
hygiene (22) 22
medical or veterinary science (22) 22
preparations for medical, dental, or toilet purposes (22) 22
male (20) 20
skin neoplasms - pathology (20) 20
surgery (20) 20
adult (18) 18
aged (18) 18
organic chemistry (18) 18
peptides (18) 18
immunotherapy (17) 17
melanoma - pathology (17) 17
middle aged (17) 17
compositions thereof (16) 16
culture media (16) 16
microorganisms or enzymes (16) 16
propagating, preserving or maintaining microorganisms (16) 16
care and treatment (15) 15
cancer (14) 14
immunology (14) 14
investigating or analysing materials by determining theirchemical or physical properties (14) 14
measuring (14) 14
metastasis (14) 14
physics (14) 14
testing (14) 14
aged, 80 and over (13) 13
animals (12) 12
melanoma - surgery (12) 12
metastatic melanoma (12) 12
mice (12) 12
skin neoplasms - surgery (12) 12
survival (12) 12
t cells (12) 12
lymphatic metastasis (11) 11
sentinel lymph node biopsy (11) 11
treatment outcome (11) 11
young adult (11) 11
analysis (10) 10
biopsy (10) 10
melanoma - therapy (10) 10
prognosis (10) 10
specific therapeutic activity of chemical compounds ormedicinal preparations (10) 10
tumor-infiltrating lymphocytes (10) 10
adolescent (9) 9
lymphocytes (9) 9
medicine & public health (9) 9
patients (9) 9
retrospective studies (9) 9
skin neoplasms - therapy (9) 9
cell line, tumor (8) 8
melanoma - immunology (8) 8
metastases (8) 8
abridged index medicus (7) 7
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (7) 7
follow-up studies (7) 7
melanoma - drug therapy (7) 7
melanoma - secondary (7) 7
research article (7) 7
responses (7) 7
adoptive cell therapy (6) 6
antibodies, monoclonal - therapeutic use (6) 6
cell biology (6) 6
combined modality therapy (6) 6
dendritic cells (6) 6
health aspects (6) 6
ipilimumab (6) 6
kaplan-meier estimate (6) 6
lymph node excision (6) 6
medicine (6) 6
melanoma - genetics (6) 6
melanoma - mortality (6) 6
neoplasm staging (6) 6
regression (6) 6
research (6) 6
skin neoplasms - mortality (6) 6
surgical oncology (6) 6
tumors (6) 6
4-1bb (5) 5
adoptive transfer (5) 5
apoptosis (5) 5
cancer therapies (5) 5
cutaneous melanoma (5) 5
disease-free survival (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text CARDIOVASCULAR TOXICITIES ASSOCIATED WITH ADOPTIVE CELL THERAPY AND INTERLEUKIN-2 INFUSION FOR ADVANCED STAGE MELANOMA
by Fradley, Michael and Damrongwatanasuk, Rongras and Kip, Kevin and Kongpakpaisarn, Kullatham and Sarnaik, Amod
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 926 - 926
  Comparing the patients who developed CV complications to those who did not, there were no significant differences in age, gender, body mass index, race, or... 
Cardiovascular | Internal Medicine | Interleukins | Melanoma | Cytokines
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Retrospective analysis of patients with sentinel lymph node (SLN) positive melanoma (MEL) who received adjuvant nivolumab (NIVO) without completion lymph node dissection (CLND)
by Eroglu, Zeynep and Babacan, Nalan and Grossmann, Kenneth F and Markowitz, Joseph and Brohl, Andrew Scott and Cisneros, Jennifer and Cruse, Wayne and Harrington, Michael and Gonzalez, Ricardo Jorge and Sarnaik, Amod and Zager, Jonathan S and Sondak, Vernon K and Khushalani, Nikhil I
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 9590 - 9590
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Current Immunotherapy Practices in Melanoma
by Rothermel, Luke D and Sarnaik, Amod A and Khushalani, Nikhil I and Sondak, Vernon K
Surgical oncology clinics of North America, 07/2019, Volume 28, Issue 3, p. 403
Immunotherapy has revolutionized the treatment of melanoma, with implications for the surgical management of this disease. Surgeons must be aware of the impact... 
Journal Article
Details down arrow
4. Full Text Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma
by Eroglu, Zeynep and Eatrides, Jennifer and Naqvi, Syeda Mahrukh Hussnain and Kim, Youngchul and Rich, Jeani and Babacan, Nalan Akgul and Brohl, Andrew S and Markowitz, Joseph and Sarnaik, Amod and Zager, Jonathan and Khushalani, Nikhil I and Sondak, Vernon K and Messina, Jane
Pigment cell & melanoma research, ISSN 1755-1471, 07/2019
Current management of locoregional and oligometastatic melanoma is typically with surgery; however, some patients are unable to undergo resection due to... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Abstract 2292: Reconstitution of myeloid derived suppressor cells after the induction of lymphopenia and TIL therapy
by Kodumudi, Krithika N and Wiener, Doris and Weber, Amy and Royster, Erica and Kelley, Linda and Sarnaik, Amod and Pilon-Thomas, Shari
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 2292 - 2292
Factors such as T regulatory (Treg) cells and myeloid derived suppressor cells (MDSC) limit the effectiveness of current immunotherapy protocols. Several... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Patterns of histologic response to neoadjuvant targeted therapy in patients with BRAF mutant melanoma
by Eroglu, Zeynep and Khushalani, Nikhil I and Rich, Jeani and Sarnaik, Amod and Zager, Jonathan S and Markowitz, Joseph and Brohl, Andrew Scott and Sondak, Vernon K and Messina, Jane
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 9584 - 9584
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Safety and efficacy of cryopreserved autologous tumor infiltrating lymphocyte therapy (LN-144, lifileucel) in advanced metastatic melanoma patients who progressed on multiple prior therapies including anti-PD-1
by Sarnaik, Amod and Khushalani, Nikhil I and Chesney, Jason Alan and Kluger, Harriet M and Curti, Brendan D and Lewis, Karl D and Thomas, Sajeve Samuel and Whitman, Eric D and Hamid, Omid and Lutzky, Jose and Pavlick, Anna C and Weber, Jeffrey S and Larkin, James M.G and Barton, Debora and Yung, Lotus and Suzuki, Sam and Fardis, Maria and Kirkwood, John M
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 2518 - 2518
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Abstract CT169: A phase II, multicenter study to assess the efficacy and safety of autologous tumor infiltrating lymphocytes (LN-144) for treatment of patients with metastatic melanoma
by Sarnaik, Amod and Curti, Brendan and Davar, Diwakar and Hamid, Omid and Lutzky, Jose and Wilson, Melissa and Kluger, Harriet and Chesney, Jason and Kim, Kevin and Phan, Giao and Thomas, Sajeve and Whitman, Eric and Larsen, Bente and Suzuki, Sam and Samberg, Nancy and Gorbatchevsky, Igor and Fardis, Maria and Kirkwood, John M
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. CT169 - CT169
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Abstract 638: Epigenetic reprograming of immune cells through selective inhibition of HDAC6 reduces suppressive phenotypes and augments anti-tumor properties of T-cells
by Sodre, Andressa L and Woods, David M and Sarnaik, Amod and Betts, Brian C and Quayle, Steven and Jones, Simon and Weber, Jeffrey
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 638 - 638
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Abstract 4978: T cell mediated immunity after combination therapy with intralesional PV-10 and co-inhibitory blockade in a melanoma model
by Weber, Amy M and Liu, Hao and Kodumudi, Krithika N and Sarnaik, Amod A and Pilon-Thomas, Shari
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 4978 - 4978
PV-10 is a 10 solution of Rose Bengal, a xanthene dye that was originally developed for ophthalmic use and later used in liver function studies. PV-10 was... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Selective histone deacetylase inhibition augments melanoma immunotherapy
by Laino, Andressa Sodre and Woods, David Michael and Sarnaik, Amod and Quayle3, Steven and Jones3, Simon S and Sotomayor, Eduardo M and Weber, Jeffrey S
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. e14521 - e14521
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text A phase 2, multicenter study to assess the efficacy and safety of autologous tumor-infiltrating lymphocytes (LN-144) for the treatment of patients with metastatic melanoma
by Sarnaik, Amod and Curti, Brendan D and Davar, Diwakar and Kirkwood, John M and Hamid, Omid and Lutzky, Jose and Wilson, Melissa and Kluger, Harriet M and Whitman, Eric D and Phan, Giao Q and Thomas, Sajeve Samuel and Lewis, Karl D and Arkenau, Hendrik-Tobias and Chesney, Jason Alan and Larsen, Bente and Gorbatchevsky, Igor and Suzuki, Sam and Samberg, Nancy Louise and Fardis, Maria
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. TPS9595 - TPS9595
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. POINT: Surgical management of lymph node basin in sentinel lymph node-positive melanoma
by Sarnaik, Amod A and Zager, Jonathan S and Sondak, Vernon K
ONCOLOGY (United States), ISSN 0890-9091, 10/2016, Volume 30, Issue 10, p. 891
Skin Neoplasms - pathology | Predictive Value of Tests | Lymph Node Excision - adverse effects | Humans | Risk Factors | Treatment Outcome | Lymphatic Metastasis | Lymph Node Excision - mortality | Melanoma - secondary | Patient Selection | Sentinel Lymph Node - pathology | Sentinel Lymph Node - surgery | Skin Neoplasms - mortality | Sentinel Lymph Node Biopsy | Melanoma - surgery | Skin Neoplasms - surgery | Melanoma - mortality
Journal Article
Details down arrow
14. Full Text Epigenetic control of CD4/CD8 lineage commitment and resistance to tumor infiltrating lymphocyte adoptive cell therapy for metastatic melanoma
by Woods, David Michael and Berglund, Anders E and Sarnaik, Amod and Weber, Jeffrey S
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 3008 - 3008
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text β-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer
by Clements, Wilson M and Wang, Jiang and Sarnaik, Amod and Kim, On Ja and MacDonald, Jack and Fenoglio-Preiser, Cecilia and Groden, Joanna and Lowy, Andrew M
Cancer Research, ISSN 0008-5472, 06/2002, Volume 62, Issue 12, pp. 3503 - 3506
Studies of Wnt activation in gastric cancer have yielded conflicting results. The goals of this study were to determine the frequency of Wnt pathway activation... 
TARGET | GENE | APC | ONCOLOGY | CARCINOMAS | CELL-LINES | ADENOMATOUS-POLYPOSIS | EXPRESSION | TUMORS | Stomach Neoplasms - genetics | Adenocarcinoma - pathology | beta Catenin | Cytoskeletal Proteins - genetics | Humans | Trans-Activators | Zebrafish Proteins | Stomach Neoplasms - metabolism | Stomach Neoplasms - pathology | Signal Transduction - genetics | Wnt Proteins | Subcellular Fractions - metabolism | Adenocarcinoma - metabolism | Cell Nucleus - metabolism | DNA Mutational Analysis | Polymerase Chain Reaction | Proto-Oncogene Proteins - physiology | Cytoskeletal Proteins - metabolism | Signal Transduction - physiology | Adenocarcinoma - genetics | Mutation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Abstract 2331: HDAC6, new role as master regulator of PD-L1 and immune-related pathways
by Knox, Tessa and Lienlaf, Maritza and Perez, Patricio and Pabon, Mibel and Lee, Calvin and Cheng, Fengdong and Sahakian, Eva and Powers, John and Deng, Susan and Keiran, Smalley and Kozikowski, Alan and Pinilla, Javier and Sarnaik, Amod and Seto, Ed and Weber, Jeffrey and Sotomayor, Eduardo and Villagra, Alejandro
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 2331 - 2331
Histone deacetylases (HDACs), originally described as histone modifiers, have more recently been demonstrated to modify a variety of other proteins involved in... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Safety and efficacy of cryopreserved autologous tumor infiltrating lymphocyte therapy (LN-144, lifileucel) in advanced metastatic melanoma patients previously treated with at least one prior systemic therapy
by Sarnaik, Amod and Thomas, Sajeve Samuel and Davar, Diwakar and Kirkwood, John M and Kluger, Harriet M and Lutzky, Jose and Wilson, Melissa and Pavlick, Anna C and Curti, Brendan D and Whitman, Eric D and Phan, Giao Q and Ernstoff, Marc S and Takamura, Kathryn Toshimi and Barton, Debora and Suzuki, Sam and Karyampudi, Lavakumar and Samberg, Nancy Louise and Fardis, Maria and Chesney, Jason Alan
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 8_suppl, pp. 136 - 136
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Efficacy of single administration of tumor-infiltrating lymphocytes (TIL) in heavily pretreated patients with metastatic melanoma following checkpoint therapy
by Sarnaik, Amod and Kluger, Harriet M and Chesney, Jason Alan and Sethuraman, Jyothi and Veerapathran, Anandharamen and Simpson-Abelson, Michelle and Lotze, Michael T and Larsen, Bente and Fischkoff, Steven A and Suzuki, Sam and Wang, Lei and Mirgoli, Mariam and Fardis, Maria and Curti, Brendan D
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 3045 - 3045
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Abstract 257: Class I HDAC inhibition upregulates PD-1 ligands in melanoma and increases the efficacy of PD-1 blockade
by Woods, David M and Sodre, Andressa L and Sarnaik, Amod and Sotomayor, Eduardo M and Weber, Jeffrey
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 257 - 257
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Abstract 3136: Adoptive transfer of bone marrow T cells induces antitumor immune responses in murine models of melanoma and neuroblastoma
by Kodumudi, Krithika N and Weber, Amy and Moore, Ellen and Sarnaik, Amod and Pilon-Thomas, Shari
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 3136 - 3136
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.